Talphera to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026
PR Newswire•04/11/2026•08:30 ET
0
Key Highlights
- ➤Talphera (TLPH) will report third-quarter 2026 financial results November 12, 2026
- ➤Conference call and webcast scheduled for 4:30 p.m. Eastern Time
- ➤Niyad is being studied under an IDE as an anticoagulant for extracorporeal circuits
- ➤FDA granted nafamostat Breakthrough Device Designation status
Talphera to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026 PR Newswire
SAN MATEO, Calif., Nov. 4, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will host a conference call and webcast on Thursday, November 12, 2026 at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss financial results for the third quarter ended September 30, 2026 and recent business progress.
Get started
Create a free account to read the full story.